Jason N. Barreto

WinnMed — United States

Medicine · Health Sciences

20h-index1.6kcitations86works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(18), Neutropenia and Cancer Infections(18), Pneumocystis jirovecii pneumonia detection and treatment(15), Bacterial Identification and Susceptibility Testing(7), Tuberculosis Research and Epidemiology(6)

Publications86 total

Pharmacist Perspectives on High-Dose Methotrexate Management and Acute Kidney Injury Risk Mitigation in Patients With Lymphoma: Results From a National Survey
Journal of Pharmacy Practice·2026
Use of a Cystatin C-Based GFR Equation in a Population Pharmacokinetic Model of Methotrexate Clearance in Adult Patients with Lymphoma
Clinical Pharmacokinetics·2026Open Access
The Clinical Pharmacist as Principal Investigator—2026
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY·2025Open Access
Efficacy and Safety of Varied Bisphosphonate Therapy Dosing in Patients With Hypercalcemia of Malignancy
JCO Oncology Practice·2025
Prognostic value of immunoparesis, lymphopenia, high serum ferritin, and suppression of the non-involved serum free light chains (niFLC) in relapsed and refractory multiple myeloma patients (RRMM) receiving bispecific antibodies
Blood·2025Open Access
Erratum: Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization
JCO Oncology Practice·2025
Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization
JCO Oncology Practice·2025· 2 cited
Comparison of outcomes in postinduction strategies for primary central nervous system lymphoma: a Mayo Clinic experience
Blood Advances·2025· 12 citedOpen Access
Clinical Cytokine Assays Early in the Course of Cytokine Release Syndrome (CRS) after CAR-T Therapy Show Difference Among Patients with Severe CRS Versus Immune Effector Cell-Associated Hemophagocytic Syndrome (IEC-HS)
Transplantation and Cellular Therapy·2025
Performance of Creatinine and Cystatin-Based Equations on Estimating Measured GFR in People with Hematological and Solid Cancers
Clinical Journal of the American Society of Nephrology·2025· 6 citedOpen Access
Glucarpidase for treatment of high-dose methotrexate toxicity
Blood·2025· 18 citedOpen Access
Challenges in renally eliminated medication use: Evaluating cystatin C and serum creatinine <scp>eGFR</scp> discordance
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy·2024· 2 citedOpen Access
Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization
Blood·2024
Cytokine Profile Comparisons Among Cytokine Release Syndrome (CRS), Macrophage Activation-like Syndrome (MAS-L) and Immune Effector Cell-Associated Hemophagocytic Syndrome (IEC-HS) in CAR-T Therapy
Blood·2024· 1 cited
Nuclear Magnetic Resonance-Based Glomerular Filtration Rate Estimation Is More Closely Associated with Serum Vancomycin Target Trough Achievement vs. Serum Creatinine-Based Equations
Journal of the American Society of Nephrology·2024
Building a robust pharmacy research program: Reflections from a large healthcare system not affiliated with a college of pharmacy
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY·2024· 3 citedOpen Access
Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With Lymphoma
JCO Oncology Practice·2024· 7 cited
Best practices for supporting and improving pharmacy resident research and quality improvement projects
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY·2023· 3 citedOpen Access
Development and validation of a model to predict acute kidney injury following high‐dose methotrexate in patients with lymphoma
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy·2023· 5 cited
Tissue Inhibitor Metalloproteinase-2 and Insulin-Like Growth Factor Binding Protein-7 Kinetics Following Exposure to High-Dose Methotrexate
Kidney360·2023· 1 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Pritish K. Tosh(17), Erin F. Barreto(13), Kristin C. Mara(13), Carrie A. Thompson(11), Ross Dierkhising(10), Andrew D. Rule(8), Nelson Leung(7), Thomas E. Witzig(5), Kianoush Kashani(4), Andrew H. Limper(4), Urshila Durani(4), Robert Christian Wolf(4), Jonathan G. Leung(4), Stephen M. Ansell(4), Lauren L. Ice(3), John C. Lieske(3), Patrick M. Wieruszewski(3), Paul J. Jannetto(3), Yi Lin(3), Huong L. Truong(3)